Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment
1996

Tumour-infiltrating lymphocytes and melanoma treatment response

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): A Hakansson, B Gustafsson, L Krysander, L Hakansson

Primary Institution: University Hospital, Linkoping, Sweden

Hypothesis

Does the presence of tumour-infiltrating lymphocytes correlate with the therapeutic effect of interferon alpha in melanoma patients?

Conclusion

The presence of CD4+ lymphocytes in tumours is associated with a better response to interferon alpha treatment in melanoma patients.

Supporting Evidence

  • Ten out of 11 patients with high CD4+ lymphocyte counts achieved tumor regression.
  • Among patients with low CD4+ lymphocyte counts, nine out of ten had progressive disease.
  • Statistically significant correlation found between CD4+ lymphocyte presence and treatment response.

Takeaway

If there are more CD4+ immune cells in a melanoma tumor, the treatment with interferon alpha is more likely to work.

Methodology

The study analyzed fine needle aspirates from melanoma patients to assess the correlation between CD4+ lymphocyte presence and treatment response to interferon alpha.

Limitations

The study did not include patients with brain metastases and had a short treatment duration for some patients.

Participant Demographics

41 patients (23 males, 18 females) with a median age of 60 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication